Keyphrases
Drug-resistant HIV
100%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
100%
Rilpivirine
100%
Active Sites
28%
Human Immunodeficiency Virus Type 1 (HIV-1)
28%
Polymerase
28%
Resistant mutants
28%
HIV-1 RT
14%
Structural Change
14%
Armamentarium
14%
Further Development
14%
Viral Variants
14%
Binding Pocket
14%
Resistance mutant
14%
Resistance Development
14%
Inhibitor Resistant
14%
Infection Assay
14%
Inhibitor Binding
14%
Nonnucleoside Reverse Transcriptase Inhibitor Resistance
14%
Viral DNA Synthesis
14%
Suboptimal Treatment
14%
Allosteric Pocket
14%
Doravirine
14%
Antiretroviral Compounds
14%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Nonnucleoside Reverse Transcriptase Inhibitor
100%
Rilpivirine
100%
Infection
12%
Antivirus Agent
12%
Virus DNA
12%
Doravirine
12%
Biochemistry, Genetics and Molecular Biology
Reverse Transcriptase
100%
Human Immunodeficiency Virus 1
100%
Active Site
25%
Polymerase
25%
DNA Synthesis
12%